BioMark Diagnostics Inc C.BUX

Alternate Symbol(s): BMKDF

BioMark Diagnostics Inc. is a liquid biopsy company. The Company is developing a molecular diagnostics technology platform, which leverages the power of metabolomics and machine learning algorithms to bring new cancer diagnostics to market and improve cancer prognosis by allowing physicians to detect carcinomas in the pre-symptomatic stages. The technology can also be used for measuring response to treatment and potentially for serial monitoring of cancer survivors. Its cancer diagnostics technology platform leverages Omics and machine learning with a focus on cancers that are hard to detect and treat cancers. Its liquid biopsy assay detects Spermidine/spermine N-acetyltransferase 1 (SSAT1). SSAT1 is an enzyme with elevated levels in numerous cancers. Its oncology has developed a new high powered liquid biopsy metabolic panel assay. The new metabolic assay is instrumental for early-stage diagnosis of lung cancer. The liquid biopsy metabolic panel has demonstrated clinical detections.

CSE:BUX - Post by User

BioMark Diagnostics Inc > What is Management doing? ABSOLUTELY NOTHING!

<< Previous

Bullboard Posts

Next >>

Comment by Lock12345on Feb 17, 2021 11:39am

130 Views

Post# 32584774

RE:What is Management doing? ABSOLUTELY NOTHING!

Rancher wrote: If there are any shareholders still watching this dead POS, you should send the a message expressing your displeasure about the absolutely crappy liquidity. I have 6500 shares and am unable to unload them even at the market price. Management should be utterly ashamed of their performance.

Rashid (CEO) is running a lifestyle company to keep family and friends employed. This is going nowhere unfortunately. Bailed on this last year.

<< Previous

Bullboard Posts

Next >>

The top 10 artificial intelligence penny stocks